Business
Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.
GUESTS
Seema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the Nordics
Lord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman Sachs
Professor Colin Garner, Co Founder and Director, Antibiotic Research UK
view more
More Episodes
Couples in Business
2019-11-21
2019-11-21
Dismissing staff
2019-11-14
2019-11-14
Business Gurus
2019-11-07
2019-11-07
Managing Conflict
2019-10-31
2019-10-31
Insolvency
2019-10-24
2019-10-24
Plant-based foods
2019-10-17
2019-10-17
Cryptocurrencies
2019-10-10
2019-10-10
The Future of Commercial Aviation
2019-07-25
2019-07-25
Lessons of Theranos
2019-07-18
2019-07-18
The investment industry - luck or judgement?
2019-07-11
2019-07-11
The discounters
2019-07-04
2019-07-04
Pivoting
2019-06-27
2019-06-27
Commerce and Crime
2019-06-20
2019-06-20
The Fitness Industry
2019-06-13
2019-06-13
The Last Mile
2019-06-06
2019-06-06
Planning for uncertainty
2019-03-28
2019-03-28
Feedback frenzy
2019-03-21
2019-03-21
Internships
2019-03-14
2019-03-14
The personalisation revolution
2019-03-07
2019-03-07
Get this podcast on your
phone, FREE
